MLTX — MOONLAKE IMMUNOTHERAPEUTICS
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 178 家机构在其最新 13F 申报中持有 MLTX(MOONLAKE IMMUNOTHERAPEUTICS),合计申报市值 $1.46B,对应 75.77M 股。按股数计算较上季度增持 10.9%(+6.44M 股),申报市值环比上升 16.8%。持仓集中度较高:前五大持有人占申报市值的 45.5%,前十大的集中度为 63.2%。
与上一季度相比,45 家新建仓位、74 家加仓、44 家减仓、19 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)的主要机构持有人包括 BVF INC/IL、Deep Track Capital, LP、T. Rowe Price Investment Management, Inc.,按 13F 申报市值在本页 372 家持有人中排名居前。
MLTX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 107 | 15.23M | $177.75M | +36.3% |
| Q2 2026 | 178 | 75.77M | $1.46B | +10.9% |
| Q1 2026 | 151 | 64.47M | $1.18B | +4.3% |
| Q4 2025 | 137 | 58.43M | $757.55M | +56.2% |
| Q3 2025 | 146 | 37.17M | $260.40M | -36.8% |
| Q2 2025 | 139 | 60.01M | $2.71B | -2.1% |
| Q1 2025 | 141 | 61.32M | $2.28B | -6.1% |
| Q4 2024 | 120 | 63.40M | $3.25B | +1.8% |
表内 8 个季度中,机构持股合计减少 76%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+56.2%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.89M | $21.66M | 0.00% | 增持 | |
| 1.80M | $21.02M | 0.04% | 增持 | |
| 1.72M | $20.10M | 0.03% | 增持 | |
| 1.40M | $16.38M | 1.86% | 持有 | |
| 1.38M | $16.14M | 0.00% | 增持 | |
| 1.02M | $11.91M | 0.00% | 增持 | |
| 703.39K | $8.23M | 0.00% | 减持 | |
| 585.70K | $6.85M | 0.06% | 增持 | |
| 544.96K | $6.40M | 0.03% | 减持 | |
| 486.69K | $5.69M | 0.01% | 增持 | |
| 377.32K | $4.41M | 0.00% | 增持 | |
| 320.80K | $3.75M | 0.00% | 增持 | |
| 223.88K | $2.62M | 0.02% | 增持 | |
| 200.32K | $2.34M | 0.00% | 增持 | |
| 190.74K | $2.23M | 0.21% | 增持 | |
| 170.83K | $2.00M | 0.01% | 增持 | |
| 138.72K | $1.62M | 0.07% | 增持 | |
| 135.33K | $1.58M | 0.00% | 增持 | |
| 135.28K | $1.58M | 0.00% | 增持 | |
| 134.34K | $1.57M | 0.41% | 减持 | |
| 118.44K | $1.39M | 0.04% | 增持 | |
| 106.24K | $1.24M | 0.05% | 增持 | |
| 105.53K | $1.23M | 0.00% | 增持 | |
| 98.01K | $1.12M | 0.00% | 减持 | |
| 89.30K | $1.04M | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.00M | $311.54M | 7.97% | 持有 | |
| 7.00M | $136.27M | 2.03% | 增持 | |
| 4.28M | $83.34M | 0.06% | 新进 | |
| 3.37M | $65.53M | 0.03% | 增持 | |
| 3.37M | $65.53M | 0.09% | 增持 | |
| 3.21M | $62.41M | 3.20% | 减持 | |
| 3.09M | $60.08M | 0.03% | 新进 | |
| 2.67M | $52.08M | 2.24% | 增持 | |
| 2.58M | $50.27M | 0.91% | 增持 | |
| 1.72M | $33.40M | 0.05% | 增持 | |
| 1.61M | $31.29M | 1.91% | 减持 | |
| 1.39M | $27.60M | 0.00% | 增持 | |
| 1.40M | $27.26M | 2.49% | 增持 | |
| 1.16M | $22.56M | 0.09% | 减持 | |
| 1.09M | $21.32M | 0.00% | 增持 | |
| 1.04M | $20.28M | 0.00% | 减持 | |
| 912.72K | $17.77M | 0.06% | 减持 | |
| 855.81K | $16.66M | 3.50% | 增持 | |
| 769.77K | $14.97M | 0.07% | 减持 | |
| 751.90K | $14.64M | 0.00% | 增持 | |
| 750.78K | $14.62M | 0.01% | 增持 | |
| 750.00K | $14.60M | 2.32% | 新进 | |
| 679.24K | $13.22M | 0.04% | 增持 | |
| 643.27K | $12.52M | 0.02% | 增持 | |
| 636.19K | $12.39M | 0.01% | 增持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.00M | $298.26M | 9.50% | 减持 | |
| 6.41M | $119.46M | 1.95% | 增持 | |
| 4.48M | $83.52M | 4.32% | 增持 | |
| 3.45M | $64.30M | 0.03% | 增持 | |
| 2.39M | $44.56M | 0.03% | 减持 | |
| 2.39M | $44.56M | 0.09% | 减持 | |
| 1.81M | $33.76M | 2.61% | 新进 | |
| 1.71M | $31.84M | 0.86% | 增持 | |
| 1.50M | $27.96M | 1.48% | 减持 | |
| 1.37M | $25.51M | 0.10% | 增持 | |
| 1.29M | $24.14M | 0.00% | 增持 | |
| 1.13M | $21.07M | 0.01% | 增持 | |
| 1.12M | $20.92M | 0.03% | 增持 | |
| 1.07M | $19.86M | 0.07% | 减持 | |
| 1.02M | $19.05M | 0.00% | 增持 | |
| 1.00M | $18.64M | 1.55% | 持有 | |
| 1.09M | $18.43M | 0.00% | 增持 | |
| 818.13K | $15.25M | 0.08% | 增持 | |
| 724.79K | $13.51M | 0.00% | 增持 | |
| 614.48K | $11.45M | 0.00% | 减持 | |
| 600.00K | $11.18M | 0.03% | 新进 | |
| 576.09K | $10.74M | 0.01% | 减持 | |
| 576.09K | $10.74M | 0.01% | 减持 | |
| 500.00K | $9.32M | 2.14% | 新进 | |
| 500.00K | $9.32M | 0.17% | 持有 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.75M | $260.32M | 8.76% | 持有 | |
| 4.61M | $60.76M | 1.08% | 新进 | |
| 4.36M | $57.40M | 2.65% | 增持 | |
| 2.48M | $32.70M | 0.02% | 增持 | |
| 2.48M | $32.70M | 0.07% | 增持 | |
| 2.10M | $27.66M | 0.01% | 增持 | |
| 1.75M | $23.07M | 1.66% | 新进 | |
| 1.57M | $20.71M | 0.07% | 增持 | |
| 1.04M | $13.77M | 0.00% | 增持 | |
| 1.00M | $13.18M | 0.85% | 新进 | |
| 959.55K | $12.65M | 0.00% | 增持 | |
| 837.74K | $11.04M | 0.00% | 增持 | |
| 802.72K | $10.58M | 0.01% | 增持 | |
| 802.72K | $10.58M | 0.02% | 增持 | |
| 784.81K | $10.34M | 0.02% | 增持 | |
| 772.50K | $10.18M | 0.04% | 增持 | |
| 637.43K | $8.40M | 0.00% | 持有 | |
| 635.90K | $8.38M | 0.04% | 增持 | |
| 500.00K | $6.59M | 0.08% | 增持 | |
| 499.10K | $6.58M | 0.14% | 增持 | |
| 425.56K | $5.61M | 0.07% | 新进 | |
| 400.00K | $5.27M | 0.19% | 新进 | |
| 380.89K | $5.02M | 0.01% | 增持 | |
| 364.00K | $4.80M | 0.45% | 增持 | |
| 348.40K | $4.59M | 0.89% | 新进 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.75M | $141.62M | 5.74% | 持有 | |
| 2.00M | $14.34M | 0.21% | 减持 | |
| 1.99M | $14.30M | 0.99% | 减持 | |
| 1.50M | $10.76M | 0.02% | 新进 | |
| 965.40K | $6.92M | 0.05% | 新进 | |
| 822.96K | $5.90M | 0.00% | 减持 | |
| 726.93K | $5.21M | 0.00% | 减持 | |
| 635.70K | $4.56M | 0.00% | 减持 | |
| 454.27K | $3.26M | 0.01% | 新进 | |
| 435.84K | $3.12M | 0.50% | 增持 | |
| 362.87K | $2.60M | 0.00% | 减持 | |
| 321.11K | $2.30M | 0.00% | 减持 | |
| 316.00K | $2.27M | 0.01% | 新进 | |
| 272.77K | $1.96M | 0.02% | 增持 | |
| 262.64K | $1.88M | 0.28% | 新进 | |
| 256.65K | $1.84M | 0.00% | 增持 | |
| 250.00K | $1.79M | 0.57% | 新进 | |
| 244.00K | $1.75M | 0.04% | 增持 | |
| 207.00K | $1.48M | 0.16% | 增持 | |
| 178.08K | $1.28M | 0.89% | 新进 | |
| 174.16K | $1.25M | 0.00% | 增持 | |
| 195.49K | $1.22M | 0.00% | 增持 | |
| 143.28K | $1.03M | 0.01% | 新进 | |
| 135.50K | $971.50K | 0.00% | 增持 | |
| 134.84K | $966.77K | 0.05% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 19.75M | $932.26M | 33.30% | 持有 | |
| 8.49M | $400.92M | 29.86% | 持有 | |
| 5.73M | $270.48M | 0.02% | 减持 | |
| 4.15M | $195.88M | 3.43% | 增持 | |
| 2.61M | $123.34M | 0.01% | 减持 | |
| 1.28M | $60.21M | 0.03% | 减持 | |
| 1.26M | $59.44M | 0.25% | 减持 | |
| 1.25M | $58.93M | 0.11% | 减持 | |
| 1.14M | $53.71M | 0.02% | 增持 | |
| 878.32K | $41.46M | 1.77% | 增持 | |
| 791.55K | $37.36M | 0.01% | 增持 | |
| 741.09K | $34.98M | 0.50% | 新进 | |
| 675.45K | $31.88M | 0.45% | 增持 | |
| 550.00K | $25.96M | 1.37% | 增持 | |
| 529.21K | $24.98M | 0.04% | 减持 | |
| 508.27K | $23.99M | 1.24% | 新进 | |
| 423.17K | $19.97M | 0.07% | 增持 | |
| 327.34K | $15.45M | 0.00% | 增持 | |
| 313.57K | $14.80M | 2.56% | 减持 | |
| 310.60K | $14.66M | 0.08% | 增持 | |
| 295.62K | $13.95M | 0.06% | 减持 | |
| 290.78K | $13.73M | 5.56% | 减持 | |
| 282.31K | $13.33M | 5.12% | 持有 | |
| 247.50K | $11.68M | 0.06% | 减持 | |
| 246.11K | $11.62M | 0.01% | 减持 |
新建仓(Q2 2026)
- T. Rowe Price Investment Management, Inc. 4.28M 股 · $83.34M
- Jupiter Topco LLC 3.09M 股 · $60.08M
- Trails Edge Capital Partners, LP 750.00K 股 · $14.60M
- Capricorn Fund Managers Ltd 374.87K 股 · $7.29M
- Burkehill Global Management, LP 250.00K 股 · $4.87M
- Verition Fund Management LLC 207.10K 股 · $4.03M
- Caption Management, LLC 128.90K 股 · $2.51M
- Engineers Gate Manager LP 111.59K 股 · $2.17M
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 110.00K 股 · $2.14M
- Quadrature Capital Ltd 109.20K 股 · $2.13M
- Polymer Capital Management (HK) LTD 100.46K 股 · $1.96M
- Ghisallo Capital Management LLC 100.00K 股 · $1.95M
完全清仓(较上季)
- Janus Henderson Group 卖出 3.45M 股 · $64.30M
- Jefferies Financial Group Inc. 卖出 500.00K 股 · $9.32M
- Casdin Capital 卖出 450.00K 股 · $8.39M
- First Turn Management, LLC 卖出 315.56K 股 · $5.88M
- Ishara Investments LP 卖出 174.25K 股 · $3.25M
- READYSTATE ASSET MANAGEMENT LP 卖出 144.24K 股 · $2.69M
- Invesco Ltd 卖出 139.57K 股 · $2.60M
- ALPS ADVISORS INC 卖出 58.40K 股 · $1.09M
- STATE STREET CORP 卖出 56.49K 股 · $1.05M
- Avidity Partners Management LP 卖出 50.00K 股 · $932.00K
- Brevan Howard Capital Management LP 卖出 32.51K 股 · $605.93K
- AXQ CAPITAL, LP 卖出 19.24K 股 · $358.65K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1.89M | 1.39M | 1.09M | 837.74K | 174.16K | 39.40K | 841 | 1.25K | 1.24K | 17.71K | 5 | 1.45K | 275.60K | 298.18K | 303.22K | 44.84K | — | — | — |
| Qube Research & Technologies Ltd | 1.80M | 496.24K | 42.92K | — | — | — | — | — | — | — | 5.66K | 18.92K | — | — | — | — | — | — | — |
| Renaissance Technologies | 1.72M | 643.27K | 276.77K | 134.47K | — | — | — | — | — | — | — | — | 13.40K | 15.50K | 22.70K | 11.61K | — | — | — |
| Vivo Capital, LLC | 1.40M | 1.40M | 1.00M | 1.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 1.38M | 1.09M | 1.02M | 286.59K | 125.38K | 327.34K | 286.21K | 368.85K | 400.79K | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1.02M | 563.60K | 614.48K | 1.04M | 256.65K | 43.24K | 54.33K | 47.14K | 130.60K | 69.03K | 229.18K | 66.51K | 9.45K | 159.43K | 32.52K | 27.36K | 3.10K | — | — |
| Arrowstreet Capital | 703.39K | 750.78K | 70.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 585.70K | 336.24K | 325.97K | 425.56K | — | — | — | — | — | 15.90K | — | — | — | — | — | — | — | — | — |
| Candriam S.C.A. | 544.96K | 769.77K | 818.13K | 134.33K | 133.64K | 144.83K | 174.52K | 227.48K | 239.00K | 239.00K | 239.00K | 185.00K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 486.69K | 341.54K | 239.84K | 11.31K | 7.30K | 6.14K | 6.33K | 7.63K | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 377.32K | 328.52K | 3.88K | 239.02K | 84.35K | 80.35K | 120.77K | 27.92K | 6.34K | 3.27K | 14.75K | 641 | 1.12K | — | 7.96K | 73.39K | 75.66K | 73.66K | — |
| JANE STREET GROUP, LLC | 320.80K | 42.10K | 26.40K | 39.00K | 21.98K | 19.30K | 25.00K | 3.72K | 6.10K | 14.70K | 17.00K | 6.00K | 4.99K | — | — | — | — | — | — |
| CONGRESS ASSET MANAGEMENT CO | 223.88K | 180.45K | 178.56K | 71.10K | 73.36K | 72.85K | 72.73K | 72.99K | 66.64K | — | — | — | — | — | — | — | — | — | — |
| Deutsche Bank AG | 200.32K | 2.89K | 2.05K | 2.05K | 2.34K | 1.55K | 903 | 903 | 565 | 565 | 565 | 565 | — | — | — | — | — | — | — |
| Polymer Capital Management (HK) LTD | 190.74K | 100.46K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 170.83K | 85.15K | 110.22K | 121.64K | 12.90K | 17.57K | 16.94K | 13.00K | 6.40K | 7.34K | — | 18.90K | 13.91K | — | — | — | — | — | — |
| Campbell & CO Investment Adviser LLC | 138.72K | 29.68K | — | 13.45K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 135.33K | — | 56.49K | 50.97K | 52.89K | 64.56K | 93.40K | 91.55K | 87.64K | 44.66K | 45.36K | 30.34K | 20.80K | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 135.28K | 130.33K | 95.34K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HighVista Strategies LLC | 134.34K | 187.95K | 193.96K | — | 19.06K | 20.95K | 43.54K | 43.54K | 43.54K | 42.25K | 59.77K | 59.77K | 59.77K | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold MLTX?
As of 2026-Q2, 178 institutional funds reported holding MLTX (MOONLAKE IMMUNOTHERAPEUTICS) in SEC 13F filings, with a combined reported value of $1.46B.
How many shares of MLTX do institutions own?
13F filers reported 75.77M shares of MLTX, worth $1.46B in aggregate at the end of 2026-Q2.
Is institutional ownership of MLTX rising or falling?
Share counts moved +10.9% versus the prior quarter — accumulation.
Who are the top institutional holders of MLTX?
The largest 13F holders are BVF INC/IL, Deep Track Capital, LP, T. Rowe Price Investment Management, Inc., D. E. Shaw & Co, D. E. Shaw & Co., Inc.; the top 25 are ranked at the top of this page.
Who are the major shareholders of MOONLAKE IMMUNOTHERAPEUTICS?
The major shareholders of MOONLAKE IMMUNOTHERAPEUTICS (MLTX) by reported 13F value are BVF INC/IL, Deep Track Capital, LP, T. Rowe Price Investment Management, Inc., D. E. Shaw & Co, D. E. Shaw & Co., Inc., among 372 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.